Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement Margareth Castro Ozelo, Sandra Vallin Antunes, Paula Ribeiro Villaca, Luciana Correa Oliveira, Ieda Solange Pinto, Claúdia Santos Lorenzato, Alessandra Nunes Loureiro Prezotti, Renato Mantelli Picoli

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues

FACTOR-VIII MIMETIC BISPECIFIC ANTIBODIES FOR THE TREATMENT OF HEMOPHILIA A: AN UPDATE VEAd Jesus, DL Almeida, RL Muniz, J Alvares-Teorodo, RM Camelo